Replies to post #56294 on Vivos Inc (RDGL)

[Chief Slapaho]

Agree. Remains to be seen if testing shows high %age success rate in both dogs and cats with NO recurrence and few if any side effects. But when the same CEO is at the helm who knew of denial at least a week prior to it last year, and word had leaked out a few days prior to news of it and the stock tanked, what could possibly go wrong here?

[Jbwnd]

No one can "prove" the cost for each dose at this point, however I look at the pet market this way, they are getting paid to do animal testing! What is the cash value of that? If it proves effective, Fantastic, we move forward with some data, if the effect is less than what is desired at least we will know that as well because no one will use it. JMO